Taifo Mahmud Selected Research

apoptolidin A

2/2015

Apoptolidins A and C activate AMPK in metabolically sensitive cell types and are mechanistically distinct from oligomycin A.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Taifo Mahmud Research Topics

Disease

4	Neoplasms (Cancer) 11/2021 - 11/2007
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2020
1	Hyperlipidemias (Hyperlipidemia) 11/2021
1	Squamous Cell Carcinoma of Head and Neck 01/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 07/2014
1	Tuberculosis (Tuberculoses) 07/2014
1	Infections 07/2014
1	Leprosy (Hansen's Disease) 07/2014
1	Dehydration (Water Stress) 02/2005

Drug/Important Bio-Agent (IBA)

1	Acarbose FDA LinkGeneric 01/2022
1	GlucosidasesIBA 01/2022
1	conglobatinIBA 11/2021
1	perlolyrineIBA 11/2021
1	sporogenIBA 10/2021
1	Insulin (Novolin)FDA Link 01/2020
1	apoptolidinIBA 02/2015
1	apoptolidin AIBA 02/2015
1	TM-025IBA 01/2015
1	TM-026IBA 01/2015
1	PactamycinIBA 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2014
1	rifamycin BIBA 07/2014
1	Epothilones (Epothilone)IBA 11/2007
1	5-diphosphomevalonic acidIBA 02/2005
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 02/2005
1	isopentenyl pyrophosphate (isopentenyl diphosphate)IBA 02/2005